rs138658585

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_016219.5(MAN1B1):​c.1433A>G​(p.Lys478Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0024 in 1,552,362 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0025 ( 1 hom., cov: 34)
Exomes š‘“: 0.0024 ( 6 hom. )

Consequence

MAN1B1
NM_016219.5 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 4.16

Publications

5 publications found
Variant links:
Genes affected
MAN1B1 (HGNC:6823): (mannosidase alpha class 1B member 1) This gene encodes an enzyme belonging to the glycosyl hydrolase 47 family. This enzyme functions in N-glycan biosynthesis, and is a class I alpha-1,2-mannosidase that specifically converts Man9GlcNAc to Man8GlcNAc isomer B. It is required for N-glycan trimming to Man5-6GlcNAc2 in the endoplasmic-reticulum-associated degradation pathway. Mutations in this gene cause autosomal-recessive intellectual disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 11. [provided by RefSeq, Dec 2011]
MAN1B1 Gene-Disease associations (from GenCC):
  • MAN1B1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Rafiq syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 9-137106303-A-G is Benign according to our data. Variant chr9-137106303-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211420.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00248 (378/152310) while in subpopulation NFE AF = 0.00316 (215/68012). AF 95% confidence interval is 0.00281. There are 1 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAN1B1NM_016219.5 linkc.1433A>G p.Lys478Arg missense_variant Exon 9 of 13 ENST00000371589.9 NP_057303.2
MAN1B1XM_006716945.5 linkc.1433A>G p.Lys478Arg missense_variant Exon 9 of 12 XP_006717008.1
MAN1B1NR_045720.2 linkn.1448A>G non_coding_transcript_exon_variant Exon 9 of 13
MAN1B1NR_045721.2 linkn.1579A>G non_coding_transcript_exon_variant Exon 10 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAN1B1ENST00000371589.9 linkc.1433A>G p.Lys478Arg missense_variant Exon 9 of 13 1 NM_016219.5 ENSP00000360645.4

Frequencies

GnomAD3 genomes
AF:
0.00248
AC:
378
AN:
152194
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0109
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00316
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00238
AC:
376
AN:
157780
AF XY:
0.00229
show subpopulations
Gnomad AFR exome
AF:
0.000334
Gnomad AMR exome
AF:
0.000242
Gnomad ASJ exome
AF:
0.000591
Gnomad EAS exome
AF:
0.0000860
Gnomad FIN exome
AF:
0.0105
Gnomad NFE exome
AF:
0.00262
Gnomad OTH exome
AF:
0.00203
GnomAD4 exome
AF:
0.00239
AC:
3345
AN:
1400052
Hom.:
6
Cov.:
32
AF XY:
0.00241
AC XY:
1662
AN XY:
690768
show subpopulations
African (AFR)
AF:
0.000219
AC:
7
AN:
31970
American (AMR)
AF:
0.000530
AC:
19
AN:
35860
Ashkenazi Jewish (ASJ)
AF:
0.000754
AC:
19
AN:
25186
East Asian (EAS)
AF:
0.0000275
AC:
1
AN:
36304
South Asian (SAS)
AF:
0.00122
AC:
97
AN:
79542
European-Finnish (FIN)
AF:
0.0103
AC:
498
AN:
48150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4356
European-Non Finnish (NFE)
AF:
0.00241
AC:
2609
AN:
1080718
Other (OTH)
AF:
0.00164
AC:
95
AN:
57966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
183
366
549
732
915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00248
AC:
378
AN:
152310
Hom.:
1
Cov.:
34
AF XY:
0.00277
AC XY:
206
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41580
American (AMR)
AF:
0.000392
AC:
6
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4824
European-Finnish (FIN)
AF:
0.0109
AC:
116
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00316
AC:
215
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00219
Hom.:
3
Bravo
AF:
0.00167
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000233
AC:
1
ESP6500EA
AF:
0.00155
AC:
13
ExAC
AF:
0.00135
AC:
144

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Rafiq syndrome Uncertain:1Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Benign:2
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MAN1B1: BP4, BS1, BS2 -

Dec 01, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 30, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 27, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

MAN1B1-related disorder Benign:1
Nov 29, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.25
T;T
Eigen
Benign
-0.067
Eigen_PC
Benign
0.041
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.89
D;D
MetaRNN
Benign
0.0077
T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
1.2
L;.
PhyloP100
4.2
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.9
N;.
REVEL
Uncertain
0.38
Sift
Benign
0.26
T;.
Sift4G
Benign
0.23
T;T
Polyphen
0.073
B;.
Vest4
0.31
MVP
0.81
MPC
0.12
ClinPred
0.011
T
GERP RS
3.9
Varity_R
0.29
gMVP
0.51
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.21
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.21
Position offset: -33

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138658585; hg19: chr9-140000755; COSMIC: COSV106110747; COSMIC: COSV106110747; API